• We are sorry, but NCBI web applications do not support your browser and may not function properly. More information
Logo of pnasPNASInfo for AuthorsSubscriptionsAboutThis Article
Proc Natl Acad Sci U S A. May 1982; 79(9): 3047–3051.
PMCID: PMC346346

Abnormal oxidative metabolism of estradiol in women with breast cancer.

Abstract

The three dominant oxidative biotransformations of estradiol were examined in 10 normal women and 33 females with breast cancer by using a recently devised radiometric method. Estradiol tracers, labeled with 3H specifically in the 17 alpha, C-2, or 16 alpha position, were used to measure both the rate and extent of 17 beta-ol oxidation (the initial metabolic step) and the subsequent 2- and 16 alpha-oxidative reactions. The mean +/- SEM values for the extent of extradiol metabolism at these three specific sites for the extent of estradiol metabolism at these three specific sites were 76.9 +/- 5.3%, 31.1 +/- 4.0%, and 9.3 +/- 0.8%, respectively in normal subjects. Corresponding data in patients with breast cancer--i.e., 73.0 +/- 4.2%, 32.7 +/- 2.7%, and 14.9 +/- 1.5%--revealed a significantly greater extent of 16 alpha-hydroxylation in the latter population. Because the 16 alpha-hydroxylated compounds (including estriol) are themselves potent estrogens, these changes may have important hyperestrogenic consequences that could have a bearing on the etiology of the disease.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (1.0M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • MacMahon B, Cole P, Brown J. Etiology of human breast cancer: a review. J Natl Cancer Inst. 1973 Jan;50(1):21–42. [PubMed]
  • Dao TL. Metabolism of estrogens in breast cancer. Biochim Biophys Acta. 1979 Dec 19;560(4):397–426. [PubMed]
  • Fishman J, Fukushima DK, O'Connor J, Lynch HT. Low urinary estrogen glucuronides in women at risk for familial breast cancer. Science. 1979 Jun 8;204(4397):1089–1091. [PubMed]
  • Morreal CE, Dao TL, Nemoto T, Lonergan PA. Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer. J Natl Cancer Inst. 1979 Nov;63(5):1171–1174. [PubMed]
  • Lemon HM, Wotiz HH, Parsons L, Mozden PJ. Reduced estriol excretion in patients with breast cancer prior to endocrine therapy. JAMA. 1966 Jun 27;196(13):1128–1136. [PubMed]
  • Thijssen JH, Poortman J, Schwarz F. Androgens in postmenopausal breast cancer: excretion, production and interaction with estrogens. J Steroid Biochem. 1975 May;6(5):729–734. [PubMed]
  • Malarkey WB, Schroeder LL, Stevens VC, James AG, Lanese RR. Twenty-four-hour preoperative endocrine profiles in women with benign and malignant breast disease. Cancer Res. 1977 Dec;37(12):4655–4659. [PubMed]
  • Hellman L, Zumoff B, Fishman J, Gallagher TF. Peripheral metabolism of 3H-estradiol and the excretion of endogenous estrone and estriol glucosiduronate in women with breast cancer. J Clin Endocrinol Metab. 1971 Jul;33(1):138–144. [PubMed]
  • FISHMAN J, BRADLOW HL, GALLAGHER TF. Oxidative metabolism of estradiol. J Biol Chem. 1960 Nov;235:3104–3107. [PubMed]
  • Clark JH, Paszko Z, Peck EJ., Jr Nuclear binding and retention of the receptor estrogen complex: relation to the agonistic and antagonistic properties of estriol. Endocrinology. 1977 Jan;100(1):91–96. [PubMed]
  • Martucci C, Fishman J. Direction of estradiol metabolism as a control of its hormonal action--uterotrophic activity of estradiol metabolites. Endocrinology. 1977 Dec;101(6):1709–1715. [PubMed]
  • Naftolin F, Morishita H, Davies IJ, Todd R, Ryan KJ. 2-hydroxyestrone induced rise in serum luteinizing hormone in the immature male rat. Biochem Biophys Res Commun. 1975 Jan 2;64(3):905–910. [PubMed]
  • Gethmann U, Knuppen R. Effect of 2-hydroxyoestrone on lutropin (LH) and follitropin (FSH) secretion in the ovarectomized primed rat. Hoppe Seylers Z Physiol Chem. 1976 Jul;357(7):1011–1013. [PubMed]
  • Fishman J, Bradlow HL, Schneider J, Anderson KE, Kappas A. Radiometric analysis of biological oxidations in man: sex differences in estradiol metabolism. Proc Natl Acad Sci U S A. 1980 Aug;77(8):4957–4960. [PMC free article] [PubMed]
  • Fishman J, Guzik H, Hellman L. Aromatic ring hydroxylation of estradiol in man. Biochemistry. 1970 Mar 31;9(7):1593–1598. [PubMed]
  • Numazawa M, Kiyono Y, Nambara T. A simple radiometric assay for estradiol 2-hydroxylase activity. Anal Biochem. 1980 May 15;104(2):290–295. [PubMed]
  • Lahita RG, Bradlow HL, Kunkel HG, Fishman J. Increased 16 alpha-hydroxylation of estradiol in systemic lupus erythematosus. J Clin Endocrinol Metab. 1981 Jul;53(1):174–178. [PubMed]
  • SCHLOERB PR, FRIIS-HANSEN BJ, EDELMAN IS, SOLOMON AK, MOORE FD. The measurement of total body water in the human subject by deuterium oxide dilution; with a consideration of the dynamics of deuterium distribution. J Clin Invest. 1950 Oct;29(10):1296–1310. [PMC free article] [PubMed]
  • Henderson IC, Canellos GP. Cancer of the breast: the past decade (first of two parts). N Engl J Med. 1980 Jan 3;302(1):17–30. [PubMed]
  • Legha SS, Davis HL, Muggia FM. Hormonal therapy of breast cancer: new approaches and concepts. Ann Intern Med. 1978 Jan;88(1):69–77. [PubMed]
  • Korenman SG. Oestrogen window hypothesis of the aetiology of breast cancer. Lancet. 1980 Mar 29;1(8170):700–701. [PubMed]
  • Rudali G, Apiou F, Muel B. Mammary cancer produced in mice with estriol. Eur J Cancer. 1975 Jan;11(1):39–41. [PubMed]
  • Noble RL, Hochachka BC, King D. Spontaneous and estrogen-produced tumors in Nb rats and their behavior after transplantation. Cancer Res. 1975 Mar;35(3):766–780. [PubMed]
  • Fishman J, Martucci C. Biological properties of 16 alpha-hydroxyestrone: implications in estrogen physiology and pathophysiology. J Clin Endocrinol Metab. 1980 Sep;51(3):611–615. [PubMed]
  • Lemon HM. Endocrine influences on human mammary cancer formation. A critique. Cancer. 1969 Apr;23(4):781–790. [PubMed]
  • Dickinson LE, MacMahon B, Cole P, Brown JB. Estrogen profiles of Oriental and Caucasian women in Hawaii. N Engl J Med. 1974 Dec 5;291(23):1211–1213. [PubMed]
  • MacMahon B, Cole P, Brown JB, Aoki K, Lin TM, Morgan RW, Woo NC. Urine oestrogen profiles of Asian and North American women. Int J Cancer. 1974 Aug 15;14(2):161–167. [PubMed]
  • Gross J, Modan B, Bertini B, Spira O, de Waard F, Thijssen JH, Vestergaard P. Relationship between steroid excretion patterns and breast cancer incidence in Israeli women of various origins. J Natl Cancer Inst. 1977 Jul;59(1):7–11. [PubMed]
  • Buell P. Changing incidence of breast cancer in Japanese-American women. J Natl Cancer Inst. 1973 Nov;51(5):1479–1483. [PubMed]
  • Morgan RW, Vakil DV, Brown JB, Elinson L. Estrogen profiles in young women: effect of maternal history of breast cancer. J Natl Cancer Inst. 1978 May;60(5):965–967. [PubMed]
  • Longcope C, Pratt JH. Relationship between urine and plasma estrogen ratios. Cancer Res. 1978 Nov;38(11 Pt 2):4025–4028. [PubMed]
  • Cole P, Cramer D, Yen S, Paffenbarger R, MacMahon B, Brown J. Estrogen profiles of premenopausal women with breast cancer. Cancer Res. 1978 Mar;38(3):745–748. [PubMed]

Articles from Proceedings of the National Academy of Sciences of the United States of America are provided here courtesy of National Academy of Sciences

Formats:

Related citations in PubMed

See reviews...See all...

Cited by other articles in PMC

See all...

Links

  • Compound
    Compound
    PubChem Compound links
  • MedGen
    MedGen
    Related information in MedGen
  • PubMed
    PubMed
    PubMed citations for these articles
  • Substance
    Substance
    PubChem Substance links

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...